Ireland
--:--IST
Priya Life Science Medicines register
Registers› Irish medicines ›Daptomycin Accordpharma 350 mg powder for solution for injection/infusion
Medicines register · Ireland

Daptomycin Accordpharma 350 mg powder for solution for injection/infusion

Authorisation PA2315/237/001 · Accord Healthcare Ireland Ltd.

Source: Health Products Regulatory Authority (HPRA), open dataset, CC BY 4.0. HPRA list dated 22 Nov 2026
Licence holder
Accord Healthcare Ireland Ltd. (all products →)
Active substance
Daptomycin
Clinical trials
2 clinical trials →
Dosage form
Powder for solution for injection/infusion
Route of administration
Intravenous use
ATC codes
J01XX, J01XX09
First authorised
17/01/2020
Prescription status
Product subject to prescription which may not be renewed (A)
Supply
Supply through pharmacies only
Legal basis
Generic application (Article 10(1) of Directive No 2001/83/EC)

Daptomycin: supply and approvals

16 authorised products on the HPRA list contain Daptomycin. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 21 Nov 2026)
US shortage (FDA)
Daptomycin Injection: resolved, updated 30 Jun 2026
Germany (BfArM)
No entry in the BfArM supply notices (checked 21 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

About this licence

National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 6 years (since 17 January 2020). The HPRA list marks it as marketed in Ireland.

Other medicines with Daptomycin in Ireland

15 other products on the HPRA list contain Daptomycin, from 7 licence holders; 7 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
Daptomycin 350 mg powder for solution for injection/infusionReddy Holding GmbHNational authorisation (PA)Marketed
Daptomycin 350 mg powder for solution for injection/infusionhameln pharma GmbHNational authorisation (PA)Marketed
Daptomycin 500 mg powder for solution for injection/infusionReddy Holding GmbHNational authorisation (PA)Marketed
Daptomycin 500 mg powder for solution for injection/infusionhameln pharma GmbHNational authorisation (PA)Marketed
Daptomycin Accordpharma 500 mg powder for solution for injection/infusionAccord Healthcare Ireland Ltd.National authorisation (PA)Marketed
Daptomycin Noridem 350 mg Powder for solution for injection/infusionNoridem Enterprises LimitedNational authorisation (PA)Marketed
Daptomycin Noridem 500 mg Powder for solution for injection/infusionNoridem Enterprises LimitedNational authorisation (PA)Marketed
Cubicin 350 mg powder for solution for injection or infusionMerck Sharp & Dohme BVCentralised EU authorisationNot stated
Cubicin 500 mg powder for solution for injection or infusionMerck Sharp & Dohme BVCentralised EU authorisationNot stated
Daptomycin Accord Healthcare 350 mg powder for solution for injection/infusionAccord Healthcare Ireland Ltd.National authorisation (PA)Not marketed
Daptomycin Accord Healthcare 500 mg powder for solution for injection/infusionAccord Healthcare Ireland Ltd.National authorisation (PA)Not marketed
Daptomycin Hospira 350 mg powder for solution for injection/infusionPfizer Europe MA EEIGCentralised EU authorisationNot stated

All 16 products with Daptomycin →

Other substances in ATC group J01XX

The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 6 other active substances share the group J01XX with this product:

Linezolid (9) · Fosfomycin trometamol (2) · Tedizolid phosphate (2) · Lefamulin (2) · Fosfomycin (1) · Linezolid (Form-III) (1)

Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.

The licence holder

Accord Healthcare Ireland Ltd. holds 235 products on the HPRA list, with 112 different active substances; 137 of the products are marked as marketed.

Shortages and approvals, every Friday

One email a week with ongoing EU and US medicine shortages, new EMA and FDA approvals and clinical trials recruiting in Ireland.

Free. Unsubscribe from any email with one click. See our privacy policy.

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.

How this page is built

The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.

This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.